Prot #NU MSK12S01: A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination with Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/14/13 → 3/14/16

Funding

  • Memorial Sloan-Kettering Cancer Center (Prot #NU MSK12S01 // Prot #NU MSK12S01)
  • National Comprehensive Cancer Network (Prot #NU MSK12S01 // Prot #NU MSK12S01)